Perceptyne Secures ₹25 Crore in Seed Funding to Drive Robotics Innovation
avatar icon
News
Written by Sirish Dixit
15 Oct, 2024
1 min read
Robotics startup Perceptyne raised ₹25 Cr in seed funding led by Endiya Partners and Yali Capital. The funds will drive the development of AI-powered robots for industries like automotive and electronics, addressing labor shortages and boosting manufacturing efficiency.
post image
Perceptyne raises ₹25 Crore to advance AI-powered robotics, enhancing automation for industries like automotive and electronics.

Hyderabad-based robotics startup Perceptyne has successfully raised ₹25 Crore in a seed funding round co-led by Endiya Partners and Yali Capital, with additional backing from Whiteboard Capital and prominent angel investors. This capital injection is set to accelerate product development, boost customer acquisition, and fuel the company’s growth trajectory.

Founded by Raviteja Chivukula, Jagga Raju Nadimpalli, and Mrutyunjaya Nadiminti, Perceptyne specializes in developing AI-powered robotics platforms designed for tasks that demand human-like precision, such as product assembly and packaging. Their flagship products, the PR-34D and PR-9D robots, incorporate advanced computer vision, AI capabilities, multi-modal sensing, and highly articulate end-effectors, making them ideal for manufacturing and assembly lines.

Perceptyne’s business model is twofold, offering both a capex option for companies to purchase the robots outright and an opex model where Perceptyne installs the robots and generates revenue based on usage. The company currently collaborates with major players in the automotive and electronics industries.

Commenting on the sector’s growth, CEO and co-founder Raviteja Chivukula said, “India’s manufacturing sector is expanding due to initiatives like Make in India, but the availability of skilled labor isn't keeping pace. AI-driven robotics will be key in addressing this gap. The global industrial robotics market is expected to reach ₹4100 Crore by 2030, with a CAGR of 12.3%.”
Was this page helpful?
Top Blog Post From Medlr
Check Out More Blogs